1. Home
  2. TRUP vs QURE Comparison

TRUP vs QURE Comparison

Compare TRUP & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trupanion Inc.

TRUP

Trupanion Inc.

HOLD

Current Price

$21.88

Market Cap

948.7M

Sector

Health Care

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$26.60

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRUP
QURE
Founded
2000
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
948.7M
1.1B
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
TRUP
QURE
Price
$21.88
$26.60
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$45.80
$45.00
AVG Volume (30 Days)
351.5K
1.6M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
295.65
29.67
EPS
0.11
N/A
Revenue
$1,439,305,000.00
$13,107,000.00
Revenue This Year
$11.79
$126.12
Revenue Next Year
$8.83
$200.43
P/E Ratio
$200.00
N/A
Revenue Growth
11.95
N/A
52 Week Low
$21.16
$8.73
52 Week High
$57.35
$71.50

Technical Indicators

Market Signals
Indicator
TRUP
QURE
Relative Strength Index (RSI) 39.79 55.52
Support Level $21.16 $23.06
Resistance Level $29.24 $29.03
Average True Range (ATR) 0.94 1.84
MACD 0.10 -0.09
Stochastic Oscillator 34.80 38.29

Price Performance

Historical Comparison
TRUP
QURE

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: